ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Anti-citrullinated Protein Autoantibodies (ACPAs)"

  • Abstract Number: 0598 • ACR Convergence 2022

    An Arthritogenic Strain of Subdoligranulum Specifically Detectable in the Feces of Individuals At-risk for and with Rheumatoid Arthritis Is Bound by ACPA and Stimulates Th17 Cell Activation in Those with Rheumatoid Arthritis

    Meagan Chriswell1, Cliff Rims2, Megan Maerz2, Alex Hsu3, Jennifer Seifert4, Marie Feser5, Michelle Bloom3, Elizabeth Bemis6, Kristen Demoruelle5, Kevin D Deane7, William Robinson8, Eddie James9, Jane Buckner9, V. Michael Holers10 and Kristi Kuhn5, 1UC Denver SOM, Aurora, CO, 2Benaroya Research Institute, Seattle, WA, 3Stanford University, Stanford, CA, 4University of Colorado, Littleton, CO, 5University of Colorado Anschutz Medical Campus, Aurora, CO, 6Colorado School of Public Health Anschutz Medical Campus, Aurora, CO, 7University of Colorado Denver Anschutz Medical Campus, Denver, CO, 8Stanford University School of Medicine, Palo Alto, CA, 9Benaroya Research Institute at Virginia Mason, Seattle, WA, 10University of Colorado, Denver, CO

    Background/Purpose: We previously demonstrated that intestinal bacteria within the families Lachnospiraceae and Ruminococcaceae are preferentially targeted by ACPA-reactive plasmablast-derived monoclonal antibodies (PB-mAbs) from dual IgA/IgG…
  • Abstract Number: 0601 • ACR Convergence 2022

    Occupational Inhaled Agents Constitute Major Risk Factors for Rheumatoid Arthritis, Particularly in the Context of Genetic Predisposition and Smoking

    Bowen Tang1, Qianwen Liu2, Anna Ilar3, Pernilla Wiebert2, Sara Hägg1, Leonid Padyukov2, Lars Klareskog2, Lars Alfredsson2 and Xia Jiang2, 1Karolinska Institutet, Solna, Sweden, 2Karolinska Institutet, Stockholm, Sweden, 3The National Board of Health and Welfare, Stockholm, Sweden

    Background/Purpose: The lung is recognized as a primary site in the induction of rheumatoid arthritis (RA). Our study aims to assess the effect of common…
  • Abstract Number: 0605 • ACR Convergence 2022

    Citrullinated Peptide-Specific ACPA Are Present in the Female Genital Tract in Premenopausal Women with and Without RA

    Daniele Marcy1, Heather Rothfuss2, Ashley Visser1, Jill Norris3, V. Michael Holers4, Kevin D Deane5, William Robinson6, Brian Cherrington2 and Kristen Demoruelle1, 1University of Colorado Anschutz Medical Campus, Aurora, CO, 2University of Wyoming, Laramie, 3Colorado School of Public Health, Aurora, CO, 4University of Colorado, Denver, CO, 5University of Colorado Denver Anschutz Medical Campus, Denver, CO, 6Stanford University School of Medicine, Palo Alto, CA

    Background/Purpose: Women develop RA ~3 times more often than men. The etiology of this sex difference remains largely unexplained. Generation of anti-citrullinated protein antibodies (ACPA)…
  • Abstract Number: 0618 • ACR Convergence 2022

    Regulation of IgA Secretion Through PAD2-mediated Citrullination of MZB1

    Bo Sun1, Benjamin Geary2, Santanu Mondal3, Ronak Tilvawala4, Konstantin Tsoyi5, Ivan O. Rosas5, Paul Thompson3 and I-Cheng Ho2, 1Brigham and Women's Hospital, Lexington, MA, 2Brigham and Women's Hospital, Boston, MA, 3UMass Medical School, Worcester, MA, 4University of Kansas, Lawrence, KS, 5Baylor College of Medicine, Houston, TX

    Background/Purpose: The secretion of antibody requires concerted action of several endoplasmic reticulum proteins (ERPs) in B cells. For example, marginal zone B and B1 cell-specific…
  • Abstract Number: 0906 • ACR Convergence 2022

    Patients with Seronegative Rheumatoid Arthritis Have a Different Ultrasound-assessed Joint Disease Phenotype Than Seropositive Patients

    Natalia Carbonell-Bobadilla1, Carina Soto-Fajardo2, Luis M Amezcua-Guerra3, Ana Beatriz Batres Marroquin4, Ana Cristina Medina5, Tania Vargas3, Adrián Hernández-Diazcouder3, Valentín Jiménez-Rojas3, Carlos Pineda5 and Luis H Silveira6, 1National Institute of Cardiology Ignacio Chávez, Ciudad de México, Mexico, 2Instituto Nacional de Rehabilitacion "Luis Guillermo Ibarra Ibarra", Ciudad de México, Mexico, 3Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, Mexico, 4Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de México, Mexico, 5Instituto Nacional de Rehabilitacion, Ciudad de México, Mexico, 6Instituto Nacional de Cardiología, Ciudad de México, Mexico

    Background/Purpose: Seronegative rheumatoid arthritis (SNRA) tends to be less severe in its presentation and evolution than seropositive rheumatoid arthritis(SPRA), but controversy exists because there have…
  • Abstract Number: 0914 • ACR Convergence 2022

    The Impact of Autoantibodies (RF and ACPA) on the Efficacy of Biological Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Meta-analysis of Randomized Controlled Trials

    Kaoru Takase-Minegishi1, Stephan Böhringer2, Jackie Nam3, Yuko Kaneko4, Frank Behrens5, Saedis Saevarsdottir6, Jacqueline Detert7, Marjatta Leirisalo-Repo8, Désirée van der Heijde9, Robert Landewé10, Sofia Ramiro11 and Diane van der Woude12, 1Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan, 2Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Leiden, Netherlands, 3Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, United Kingdom, 4Keio University School of Medicine, Tokyo, Japan, 5CIRI/Rheumatology and Fraunhofer Institute, Translational Medicine and Pharmacology ITMP, Goethe University, Frankfurt, Germany, 6Division of Clinical Epidemiology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden and Faculty of Medicine, University of Iceland, Stockholm, Sweden, 7Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany, 8Department of Rheumatology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, 9Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands, Leiden, Netherlands, 10Amsterdam University Medical Center, Meerssen, Netherlands, 11Leiden University Medical Center, Leiden, Netherlands, 12Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: The impact of autoantibodies on the efficacy of bDMARDs in patients with rheumatoid arthritis (RA) is not yet clear. Despite the fact that this…
  • Abstract Number: 1203 • ACR Convergence 2022

    The Association Between Anti-Citrullinated Peptide Antibodies and Subclinical Interstitial Lung Disease in Community-Dwelling Adults: The Multi-Ethnic Study of Atherosclerosis

    Jenna Lanz1, Jan Hughes-Austin2, Anna Podolanczuk3, John Kim4, John Austin5, William Robinson6, Ganesh Raghu7, Eric Hoffman8, John Newell Jr8, Jubal Watts Jr9, P. Hrudaya Nath9, Sushilkumar Sonavane10, R. Graham Barr5 and Elana Bernstein1, 1Columbia University, New York, NY, 2University of California, San Diego, San Diego, CA, 3Weill Cornell Medical College, New York, NY, 4University of Virginia School of Medicine, Charlottesville, VA, 5Columbia University Medical Center, New York, NY, 6Stanford University School of Medicine, Palo Alto, CA, 7University of Washington, Seattle, WA, 8University of Iowa, Iowa City, IA, 9University of Alabama at Birmingham, Birmingham, AL, 10Mayo Clinic, Rochester, MN

    Background/Purpose: We previously demonstrated a significant association between serum anti-CCP levels and prevalence of interstitial lung abnormalities (ILA) in community-dwelling adults. A greater number of…
  • Abstract Number: 1406 • ACR Convergence 2022

    Integrative Multi-omic Phenotyping in Blood Identifies Molecular Signatures and Candidate Biomarkers of ACPA-negative Rheumatoid Arthritis

    Benjamin Hur1, Kevin Cunningham2, John Davis1 and Jaeyun Sung1, 1Mayo Clinic, Rochester, MN, 2University of Minnesota, Rochester, MN

    Background/Purpose: ACPA detection assays are often used for RA diagnosis due to their high specificity ( >90%). However, current ACPA assays (e.g., anti-CCP2 ELISA) have…
  • Abstract Number: 0021 • ACR Convergence 2021

    Unique Alterations in Circulating T Peripheral Helper Cells Are Found in Different Ethnic Groups of ACPA+ Individuals Both At-risk for and with Classified RA

    Hideto Takada1, Yuko Okamoto2, Yasuhiro Katsumata3, Jennifer Seifert4, Kristen Demoruelle5, Jill Norris6, Kevin Deane7, Masayoshi Harigai3 and V. Michael Holers8, 1Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Japan, 2Tokyo Women's Medical University Division of Rheumatology, 10-22 Kawada-cho, Shinjyuku-ku, Tokyo, Japan, 3Tokyo Women's Medical University School of Medicine, Tokyo, Japan, 4University of Colorado School of Medicine, Littleton, CO, 5University of Colorado Anschutz Medical Campus, Aurora, CO, 6Colorado School of Public Health, Aurora, CO, 7University of Colorado Denver, Denver, CO, 8University of Colorado, Denver, CO

    Background/Purpose: Production of autoantibodies following pathogenic T and B cell interactions precede the development of RA. T follicular helper (Tfh) cells and T peripheral helper…
  • Abstract Number: 1214 • ACR Convergence 2021

    Examining the Relationship Between Shared Epitope, ACPA Seropositivity, and Real-World Drug Effectiveness in Patients with Rheumatoid Arthritis

    Kristin Wipfler1, Joshua Baker2, Harlan Sayles3, Xue Han4, Sang Hee Park4, Keith Wittstock4, Ted Mikuls3 and Kaleb Michaud3, 1FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 2University of Pennsylvania, Philadelphia, PA, 3University of Nebraska Medical Center, Omaha, NE, 4Bristol Myers Squibb, Princeton, NJ

    Background/Purpose: The shared epitope (SE) is an amino acid sequence motif coded by several HLA-DRB1 alleles that are overrepresented among people with rheumatoid arthritis (RA).…
  • Abstract Number: 0033 • ACR Convergence 2021

    Impaired Adipose Tissue Function in Rheumatoid Arthritis: Association with Autoimmunity, Disease Activity and Therapeutic Response

    Iván Arias de la Rosa1, alejandro Escudero2, Cristobal Román-Rodriguez2, Rocio Guzmán-Ruiz2, Maria del Mar Malagón2, Carlos Pérez-Sánchez3, Chamaida Plasencia-Rodríguez4, Ana Martinez-Feito5, Maria del Carmen Ábalos-Aguilera2, Alejandra Patiño-Trives6, Jerusalem Calvo2, Rafaela Ortega2, Eduardo Collantes-Estevez2, Chary Lopez-Pedrera2 and Nuria Barbarroja1, 1University of Cordoba/IMIBIC/Reina Sofia Hospital, Cordoba, Spain, 2IMIBIC/Reina Sofia Hospital/University of Córdoba, Córdoba, Spain, 3IMIBIC, Córdoba, Spain, 4Immuno-Rheumatology Research Group, Hospital La Paz Institute for Health Research-IdiPAZ, Rheumatology, La Paz University Hospital, Madrid, Spain, 5ImmunoRheumatology Department, IDIPAZ, Madrid, Spain, 6Rheumatology Department, Reina Sofia University Hospital/ Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ University of Cordoba, Cordoba, Spain

    Background/Purpose: 1) to evaluate the relationship among adipose tissue dysfunction, autoimmunity and disease activity in rheumatoid arthritis (RA) patients; 2) to analyze the direct effect…
  • Abstract Number: 1243 • ACR Convergence 2021

    Real World Validation of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis: Analysis from the RISE Registry

    Huifeng Yun1, Jeffrey Curtis2, Lang Chen3, cassie Clinton3, Hubert van Hoogstraten4, Stefano Fiore4, Markus Rehberg5 and Ernest Choy6, 1University of Alabama Birmingham, Birmingham, AL, 2Division of Clinical Immunology and Rheumatology, Department of Medicine, Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, 3University of Alabama at Birmingham, Birmingham, AL, 4Sanofi, Bridgewater, NJ, 5Sanofi, Franfurt, Germany, 6CREATE Centre, Cardiff University, Cardiff, Wales, United Kingdom

    Background/Purpose: Accurately identifying patients who may respond better to a specific drug or mechanism of action could improve rational selection of medications to optimize clinical…
  • Abstract Number: 0034 • ACR Convergence 2021

    Immune Complexes Contain Novel Acetylated Antigens in the Synovial Fluid of RA Patients

    Khetam Ghannam1, Holger Bang2, Thomas Häupl1, Eugen Feist3 and Gerd Burmester4, 1Charite University Medicine Berlin, Berlin, Germany, 2Orgentec Diagnostika GmbH, Mainz, Germany, Mainz, Germany, 3Helios Department of Rheumatology, Vogelsang-Gommern, Germany, 4Charité University Medicine Berlin, Berlin, Germany

    Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease characterized by genetic predisposition and associated immunological features including the production of autoantibodies against various epitopes. Several…
  • Abstract Number: 1648 • ACR Convergence 2021

    Increasing Rates of Positivity of Autoantibodies Indicates a Shorter Time-to-Diagnosis of Future Rheumatoid Arthritis

    Dylan Bergstedt1, Ryan Peterson2, Marie Feser1, LauraKay Moss1, Geoffrey Thiele3, Ted Mikuls3, Jess Edison4, V. Michael Holers1 and Kevin Deane5, 1University of Colorado Denver, Aurora, CO, 2Colorado School of Public Health, Aurora, CO, 3University of Nebraska Medical Center, Omaha, NE, 4Walter Reed National Military Medical Center, Bethesda, MD, 5University of Colorado Denver, Denver, CO

    Background/Purpose: Rheumatoid arthritis (RA) has a ‘pre-RA’ period that can be defined by elevations in autoantibodies to citrullinated protein antigens (ACPA) and rheumatoid factor (RF)…
  • Abstract Number: 0037 • ACR Convergence 2021

    Identification and Validation of Four Circulating Autoantibodies Associated with the ACPA Status in Early Rheumatoid Arthritis

    Lucía Lourido1, Cristina Ruiz-Romero2, Lidia Collado1, Monika Hansson3, Lars Klareskog4, Ronald Sjöberg5, Elisa Pin5, Peter Nilsson5 and Francisco Blanco-García6, 1Unidad de Proteómica. Grupo de Investigación de Reumatología (GIR). Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). C/ As Xubias de Arriba 84, 15006, A Coruña, España., A Coruña, Spain, 2Unidad de Proteómica. Grupo de Investigación de Reumatología (GIR). Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). C/ As Xubias de Arriba 84, 15006, A Coruña, España.Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN). Av. Monforte de Lemos, 3-5. Pabellón 11, 28029, Madrid, España., A Coruña, Spain, 3Division for Rheumatology, Karolinska Institutet, Stockholm, Sweden, 4Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, 5Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology & SciLifeLab, Stockholm, Sweden, 6Unidad de Proteómica. Grupo de Investigación de Reumatología (GIR). Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). C/ As Xubias de Arriba 84, 15006, A Coruña, España.Universidade da Coruña (UDC), Grupo de Investigación de Reumatología y Salud (GIR-S). Departamento de Fisioterapia, Medicina y Ciencias Biomédicas, Facultad de Fisioterapia, Campus de Oza, 15008, A Coruña, España., A Coruña, Spain

    Background/Purpose: The presence of anti-citrullinated protein antibodies (ACPAs) is a highly specific hallmark of rheumatoid arthritis (RA), that is present also in early disease. However,…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology